Last 7.60
Change Today +0.10 / 1.33%
Volume 30.8K
ALMD On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

allium medical solutions ltd (ALMD) Snapshot

Open
$7.80
Previous Close
$7.50
Day High
$7.80
Day Low
$7.60
52 Week High
10/23/13 - $23.54
52 Week Low
10/12/14 - $7.50
Market Cap
32.8M
Average Volume 10 Days
329.5K
EPS TTM
$-0.19
Shares Outstanding
431.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALLIUM MEDICAL SOLUTIONS LTD (ALMD)

Related News

No related news articles were found.

allium medical solutions ltd (ALMD) Related Businessweek News

No Related Businessweek News Found

allium medical solutions ltd (ALMD) Details

Allium Medical Solutions Ltd., a medical device company, develops, manufactures, and markets minimally invasive products in Israel and internationally. It offers urology products, such as ureteral, round posterior, triangular prostatic, and bulbar stents; and gastroenterology products, including biliary stents for use in chronic Common Bile Duct obstructions for allowing intra-luminal flow. The company also provides uro-gynecology products consisting of EndoFast Reliant Systems for reinforcement of the vaginal wall; EndoFast Resorb kits for fixation of surgical mesh to tissues for tissue reinforcement; EndoFast Reliant MN, an implantable, sub-urethral support sling for the treatment of male stress urinary incontinence; and EndoFast Reliant SCP for fixation of surgical mesh to tissue for tissue reinforcement during laparotomy or laparoscopic Sacrocolpopexy approach. In addition, it offers cardiovascular products comprising WIRION, a distal embolic protection system. The company is headquartered in Caesarea, Israel.

Founded in 2001

allium medical solutions ltd (ALMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

allium medical solutions ltd (ALMD) Key Developments

Allium Medical Ltd. Receives Medical Device Approval to Market its Patented EndoFast Reliant SCP and EndoFast Reliant LAP Systems

Allium Medical Ltd. announced that it received medical device approval for the marketing of its patented EndoFast Reliant SCP and EndoFast Reliant LAP systems, for soft tissue fixation using minimally invasive laparoscopic procedures for treating Pelvic Organ Prolapse Repair in women. EndoFast Reliant SCP is a full kit, which includes a unique fixation device and a supportive mesh, while EndoFast Reliant LAP includes the fixation device only. These systems are already FDA and CE approved. The EndoFast Reliant SCP and EndoFast Reliant LAP systems are specially indicated for sacrocolpopexy, correction of prolapse of organs by elevating the vagina and connecting it to the sacrum using a supportive mesh. The product makes use of the company's unique, patented spider fastener, which allows for maximum pull out force and minimal penetration depth, using a small number of fasteners while significantly reducing the risk of vascular damage. This way, better and safer results, faster recovery of patients and fewer foreign objects in the body are obtained. The innovative products of the company allows the physician to achieve optimal results relative to the solutions of competing companies. This product is particularly important in view of the growing global trend to treat female pelvic floor organ prolapse using a minimally invasive laparoscopic approach.

Allium Enters into Agreement with National University of Singapore

Allium Medical has announced the signing of agreements with the National University of Singapore (NUS). The development and commercialization project, of USD 2.2 million, is being supported with 45% funding from the Singapore-Israel Industrial R&D Foundation (SIIRD). The project will involve technological, clinical, regulatory and commercial cooperation between the two parties, which will have an equal share in additional funding over the SIIRD contribution.

Allium Medical Solutions Ltd. Auditor Raises 'Going Concern' Doubt

Allium Medical Solutions Ltd. filed its Annual on Mar 13, 2014 for the period ending Dec 31, 2013. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMD:IT 7.60 +0.10

ALMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALMD.
View Industry Companies
 

Industry Analysis

ALMD

Industry Average

Valuation ALMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLIUM MEDICAL SOLUTIONS LTD, please visit www.allium-medical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.